Abstract:Abstract Background Lyme disease is the most common pediatric tickborne infection. Due to largely disproven concerns of doxycycline-related dental staining among patients < 8 years old, no prospective data exist on efficacy and adverse effects in young children with Lyme disease. Based on emerging data, our institution has used doxycycline during the past decade when alternatives cannot be given. Our study aims to describe short-term adverse effects and treatment failures among young children receiving oral doxycycline for Lyme disease. Methods Retrospective chart review of patients < 8 years old within the Stony Brook Medicine system from 2010-2020. Patients were identified by ICD-9/-10 codes for Lyme disease prescribed doxycycline at the same visit. We excluded those lacking an objective finding of Lyme disease, including single or multiple erythema migrans (EM), facial nerve palsy, carditis, meningitis (headache with pleocytosis >5 WBC/μL), and/or arthritis, those with an alternative diagnosis, and those receiving post-tick exposure prophylactic doxycycline. Data collected included demographics, symptoms, laboratory results, treatments, and outcomes. Descriptive statistics were calculated. Results 32 charts were included. Average age was 5.1 years. 66% were male. The majority of the patients presented with a single EM (Table for presenting symptoms). Initial antibiotics were doxycycline (63%) or a beta-lactam (37%). Rationale for doxycycline included beta-lactam allergy or intolerance (47%), required for treatment of clinical syndrome (such as CNS disease) (28%), concern for alternative tickborne infection (3%), and no reason given (22%). There were no severe adverse reaction to doxycycline; 2 patients stopped due to nausea/vomiting and 1 due to refusal of oral medications. Among the 29 patients who completed doxycycline, there were no known Lyme disease treatment failures. Presenting symptoms of children <8 years old treated with doxycycline for Lyme disease Total percent exceeds 100% due to patients presenting with multiple symptoms. Percent calculation based on all included patients (n = 32). Conclusion In this small cohort of young children with Lyme disease, doxycycline was generally well-tolerated, without severe short-term adverse effects, and resulted in no treatment failures. As there is no prospective data evaluating doxycycline in this population and future randomized trials are unlikely, the data presented provides reassurance that doxycycline is effective and safe for this indication. Disclosures All Authors: No reported disclosures.

S3355 Recurrent Doxycycline Induced Esophagitis – Recurrent on Board Exams, Rarer in Reality

EoE Recurrence on PPI Maintenance Therapy: You Do Not Know if You Do Not Look!

Doxycycline-associated acute pancreatitis: a rare adverse effect of a commonly prescribed antibiotic

Tetracycline-, Doxycycline-, Minocycline-Induced Pseudotumor Cerebri and Esophageal Perforation

S3399 Pill Swallowing: A Case of Misdirection - Hydroxychloroquine Induced Pill Esophagitis Complicated by an Aberrant Right Subclavian Artery

987 Intestinal Epithelial Endocytosis of Commensal Bacteria is Dependent on Phosphorylation of Terminal Web Myosin by Myosin Light Chain Kinase in Bowel Obstruction

The combined effect of systemic antibiotics and proton pump inhibitors on Clostridioides difficile infection and recurrence

S3102 Eosinophilic Colitis: A Novel Aggressive Endoscopic Presentation and Its Successful Therapeutic Management

S3935 Recurrent Clostridioides difficile Infection in Crohn's Disease: A Case Series

S3264 Case Report: A Rare Case of Eosinophilic Duodenitis With Negative Biopsies

Medication-induced esophageal injury: survey of the literature

1335. Retrospective evaluation of doxycycline for the treatment of Lyme disease among young children

S619 Clinicians Report Uncertainty Regarding Approaches to Treatment Beyond Proton Pump Inhibitors in Eosinophilic Esophagitis

S3490 A Case of the Bright Blue Esophagus: A Rare Endoscopic and Histopathologic Finding

Primary and Specialty Care Trainees’ Perceptions About Proton Pump Inhibitor Use

Management of Recurrence after Peroral Endoscopic Myotomy and Submucosal Tunneling Endoscopic Septum Division.

An Unusual Case Report and Review of the Literature

Elimination Diet or Swallowed Topical Steroid Treatment of Pediatric Eosinophilic Esophagitis: Five-Year Outcomes

Omeprazole-Associated Atypical Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in a Patient with Positive In Vitro Diagnostic Testing to Multiple Proton Pump Inhibitors

Recurrence of exostosis as a result of medication-induced bruxism: case study

A study of extraesophageal presentations in gastroesophageal reflux disease]